AZoLifeSciences on MSN
Longevity Gene from Centenarians Reverses Heart Damage in Rare Genetic Disorder
A new breakthrough in a rare genetic disease which causes children to age rapidly has been discovered using 'longevity genes' ...
14hon MSN
Longevity gene from supercentenarians offers hope for disease that causes rapid aging in children
A new breakthrough in a rare genetic disease which causes children to age rapidly has been discovered using 'longevity genes' ...
Researchers from the University of Bristol and IRCCS MultiMedica showed that a gene linked to supercentenarians’ longevity ...
THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK ...
LONDON, UNITED KINGDOM / ACCESS Newswire / September 30, 2025 / Genflow (LSE:GENF)(OTCQB:GENFF) is pleased to announce its half year results for the six-month period ended 30 June 2025. Chairman's ...
This small London-listed company has been quietly advancing a gene therapy programme that could place it years ahead of the ...
A new study published recently in Cell Reports Medicine provides is one of the most thorough examinations yet of a ...
TipRanks on MSN
Genflow Biosciences Raises £340,000 Through Share Issuance
Genflow Biosciences Plc ( ($GB:GENF) ) has issued an update. Genflow Biosciences Plc has announced a successful fundraising of £340,000 through ...
(Alliance News) - Genflow Biosciences PLC on Friday reported strong data from a proof-of-concept clinical trial of its proprietary SIRT6-centenarian gene therapy for age-related decline in elderly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results